The unanticipated costs of COVID-19 to South Africa’s quadruple disease burden

K Hofman; S Madhi

doi:10.7196/SAMJ.2020.v110i8.15125

Guest Editorial

The unanticipated costs of COVID-19 to South Africa’s quadruple disease burden

K Hofman, S Madhi

Abstract

Authors' affiliations

K Hofman, SAMRC/Wits Centre for Health Economics and Decision Science, PRICELESS, University of the Witwatersrand School of Public Health, Faculty of Health Sciences, Johannesburg, South Africa

S Madhi, Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation, Vaccine-Preventable Diseases Research Chair, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa